dapagliflozin
Edistride, Forxiga · ATC code A10BK01
Brand names: Edistride, Forxiga, Dapagliflozin +pharma, Dapagliflozin Accord, Dapagliflozin Devatis, Dapagliflozin Genericon, Dapagliflozin Reddy, Dapagliflozin Sandoz, Dapagliflozin Stada, Dapagliflozin Tad, Odelniqva, Daglin, Figozap, Zinodap, Calira …
- Key facts
- Active substance
- dapagliflozin
- Drug class
- Gliflozins
- ATC code
- A10BK01
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Edistride 5 mg film-coated tablets / Edistride 10 mg film-coated tablets · Forxiga 5 mg film-coated tablets / Forxiga 10 mg film-coated tablets
- Marketing authorisation holder
- AstraZeneca AB
- Information as of
- 2026-10-27
Key facts
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used in type 2 diabetes mellitus, symptomatic chronic heart failure and chronic kidney disease (Forxiga, Edistride).
What it is used for
- Insufficiently controlled type 2 diabetes in adults and children aged 10 years and above, as an adjunct to diet and exercise: monotherapy when metformin is not tolerated, or added to other diabetes medicines
- Symptomatic chronic heart failure in adults
- Chronic kidney disease in adults
Dosing
- All three indications: 10 mg once daily
- With insulin or an insulin secretagogue (e.g. a sulphonylurea): consider a lower dose of these (hypoglycaemia risk)
- No dose adjustment based on renal function; initiation not recommended at GFR < 25 mL/min
- Type 2 diabetes: glucose-lowering efficacy reduced at GFR < 45 mL/min; consider additional treatment if needed
- Severe hepatic impairment: starting dose 5 mg, increase to 10 mg if well tolerated
- Missed dose: take within 12 hours, otherwise skip
Contraindications
- Hypersensitivity to the active substance or any excipient
Important warnings
- Should not be used in type 1 diabetes
- Diabetic ketoacidosis, rare but potentially fatal, possibly with only moderately raised glucose; assess immediately if non-specific symptoms occur
- Necrotising fasciitis of the perineum (Fournier's gangrene), rare but life-threatening
- Volume depletion and hypotension, especially in the elderly and with diuretics
- Urinary tract infections; consider temporary interruption for pyelonephritis or urosepsis
- Increase in lower limb amputations (primarily toe) seen with SGLT2 inhibitors; counsel on preventive foot care
Side effects
- Most frequent: genital infections (vulvovaginitis, balanitis)
- Common: urinary tract infection, dizziness, back pain, polyuria, rash
- Hypoglycaemia when used with a sulphonylurea or insulin
- Rare: diabetic ketoacidosis; Fournier's gangrene and angioedema have been reported
Interactions
- Thiazide and loop diuretics: added diuresis, risk of dehydration and hypotension
- Insulin and insulin secretagogues: hypoglycaemia risk; lower dose may be required
- Urine glucose tests will be positive during treatment
Pregnancy and breastfeeding
- Not recommended in the second and third trimesters; discontinue when pregnancy is detected
- Should not be used while breast-feeding
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- Dapagliflozin Viatris · genericViatris Limited · EMEA/H/C/006006
- EdistrideAstraZeneca AB · EMEA/H/C/004161
- ForxigaAstraZeneca AB · EMEA/H/C/002322
Source: European Medicines Agency (EMA), product information
Austria
- Dapagliflozin +pharma+pharma Arzneimittel Gmbh · 1 register entry
- Dapagliflozin AccordAccord Healthcare B.V. · 1 register entry
- Dapagliflozin DevatisDevatis Gmbh · 1 register entry
- Dapagliflozin GenericonGenericon Pharma Gesellschaft M.B.H. · 1 register entry
- Dapagliflozin ReddyReddy Holding Gmbh · 1 register entry
- Dapagliflozin SandozSandoz Gmbh · 1 register entry
- Dapagliflozin StadaStada Arzneimittel Gmbh · 1 register entry
- Dapagliflozin TadTad Pharma Gmbh · 1 register entry
- OdelniqvaPharmapath Sa · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- DaglinZaklady Farmaceutyczne Polpharma S.A. · 1 register entry
- Dapagliflozin123 Acurae Pharma Gmbh, Ratiopharm Gmbh, Puren Pharma Gmbh & Co. Kg, Macleods Pharma España, S.L.U, Devatis Gmbh, Vivanta Generics S.R.O, Ascend Gmbh, Elpen Pharmaceutical Co. Inc., Betapharm Arzneimittel Gmbh, Denk Pharma Gmbh & Co. Kg, Tad Pharma Gmbh · 12 register entries
- FigozapBasics Gmbh · 1 register entry
- ZinodapFarmitalia S.R.L. · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- CaliraSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- DaniptaİLKO İLAÇ SAN.VE TİC. A.Ş. · 4 register entries
- DapadapSANDOZ İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- DapgeonGENVEON İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- DapitusEİP ECZACIBAŞI İLAÇ PAZARLAMA A.Ş · 2 register entries
- DapligSABA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- DaprenzaBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- ForzigaASTRAZENECA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 4 register entries
- GlazoneSANTA FARMA İLAÇ SAN. A.Ş. · 2 register entries
- GlyxarALİ RAİF İLAÇ SAN. A.Ş. · 2 register entries
- JaglifNOBEL İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- TrenicatGÜREL İLAÇ TİC. A.Ş. · 2 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 28 more European countries
- Belgium
- Dapagliflozin Ab, Dapagliflozin Eg, Dapagliflozin Sandoz, Dapagliflozine Hcs
- Bulgaria
- Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma, Дагетия, Даграфорс, Далзиор, Дапаглифлозин Полфарма, Дапалиф, Дапастада, Фивота
- Croatia
- Daforbis, Dagrafors, Dalzior, Dapagliflozin Frontier, Dapagliflozin Stada, Daplemsen, Rizegmef, Zemryda
- Cyprus
- Daforbis, Dapagliflozin Farmoz, Dapagliflozin Sandoz, Dapagliflozin Stada, Dapagliflozin Tad, Dofliga, Fordapa
- Czechia
- Dagetia, Dagrafors, Dapagliflozin Fmk, Dapagliflozin Polpharma, Dapagliflozin Reddy, Dapagliflozin Sandoz, Dapagliflozin Stada, Daplemsen, Fivotta, Odelniqva
- Denmark
- Dapagliflozin, Dofliga, Figozap
- Estonia
- Dagrafors, Dapagliflozin Alembic, Dapagliflozin Olpha, Dapagliflozin Stada, Daplemsen, Fivotta, Rizegmef
- Finland
- Dapagliflozin Devatis, Dapagliflozin Krka, Dapagliflozin Orion, Dapagliflozin Ratiopharm, Dapagliflozin Sandoz, Dapagliflozin Stada, Figozap
- France
- Dapagliflozine Accord, Dapagliflozine Arrow, Dapagliflozine Biogaran, Dapagliflozine Eg, Dapagliflozine Krka, Dapagliflozine Olpha, Dapagliflozine Pharmaki, Dapagliflozine Sun, Dolpeaqio
- Greece
- Brolertix, Daforbis, Dagrafors, Dapagliflozin Sandoz, Dapagliflozin Stada, Dapagliflozin Win Medica, Dapaglut, Darxipa, Dofliga
- Hungary
- Dagrafors, Dapagliflozin Sandoz, Daperin, Dolpeaqio, Fivotta, Odelniqva, Pilagan, Zedilarf
- Iceland
- Dapagliflozin Krka, Dapagliflozin Sandoz, Dapagliflozin Viatris, Edistride, Forxiga
- Ireland
- Dapagliflozin Clonmel, Dapagliflozin Krka, Dapagliflozin Msn, Dapagliflozin Rowex
- Italy
- Dapagliflozin Aurobindo, Dapagliflozin Doc, Dapagliflozin Dr. Reddy’s, Dapagliflozin Krka, Dapagliflozin Teva, Dapaglifozin Tecnigen, Figozap, Valkozin, Zinodap
- Latvia
- Daglin, Dagrafors, Dapagliflozin Olpha, Dapagliflozin Polpharma, Dapagliflozin Stada, Daplemsen, Fivotta, Rizegmef
- Liechtenstein
- Dapagliflozin Viatris, Edistride, Forxiga
- Lithuania
- Dagrafors, Dapagliflozin Accord, Dapagliflozin Olpha, Dapagliflozin Polpharma, Dapagliflozin Stada, Daplemsen, Fivotta, Rizegmef
- Luxembourg
- Dapagliflozin Eg
- Malta
- Dapagliflozin Ascend, Dapagliflozin Aurobindo, Dapagliflozin Clonmel, Dapagliflozin Denk, Dapagliflozin Sandoz, Dapagliflozin Torrent, Pilagan
- Netherlands
- Dapagliflozin Alembic, Dapagliflozin Amarox, Dapagliflozin Aurobindo, Dapagliflozin Sandoz, Dapagliflozine Accord, Dapagliflozine Amarox, Dapagliflozine Cf, Dapagliflozine Devatis, Dapagliflozine Hcs, Dapagliflozine Macleods, Dapagliflozine Reddy, Dapagliflozine Steden Pharma, Dapagliflozine Vivanta, Daplemsen, Daplozy, Figozap, Rizegmef, Rizegmeg
- Norway
- Dapagliflozin Accord, Dapagliflozin Alembic, Dapagliflozin Devatis, Dapagliflozin Krka, Dapagliflozin Orion, Dapagliflozin Sandoz, Dapagliflozin Stada, Dapagliflozin Viatris, Dapagliflozin Vivanta, Edistride, Figozap, Forxiga
- Poland
- Daforbis, Dagrafors, Dalzior, Dapagliflozin Aurovitas, Dapagliflozin Stada, Dapazyna, Dapheria, Daplemsen, Diaflix, Figozap, Fivotta, Nerila, Odelniqva, Rizegmef, Zedilarf
- Portugal
- Dalzior, Dapagliflozin Ipca, Dapagliflozina Anova, Dapagliflozina Bluepharma, Dapagliflozina Farmak, Dapagliflozina Generis, Dapagliflozina Ipca, Dapagliflozina Krka, Dapagliflozina Pentafarma, Dapagliflozina Sandoz, Dapagliflozina Stada, Dapagliflozina Tad, Dapagliflozina Tecnigen, Dapaglifozina Aurovitas, Daperin
- Romania
- Daforbis, Dagetia, Dagrafors, Dapagliflozin Dr. Reddy’s, Dapagliflozin Stada, Daplemsen, Figozap, Fivotta, Rizegmef
- Slovakia
- Dagetia, Dagrafors, Dapagliflozin Olpha, Dapagliflozin Stada, Rizegmef
- Slovenia
- Dagrafors, Dapagliflozin Hcs, Dapagliflozin Krka, Dapagliflozin Stada, Daplemsen
- Spain
- Daforbis, Dapagliflozina Aurovitas, Dapagliflozina Combix, Dapagliflozina Dr. Reddys, Dapagliflozina Juta, Dapagliflozina Krka, Dapagliflozina Mabo, Dapagliflozina Normon, Dapagliflozina Olpha, Dapagliflozina Sandoz, Dapagliflozina Stada, Dapagliflozina Tarbis, Dapagliflozina Tecnigen, Dapagliflozina Teva, Dapagliflozina Vivanta, Daperin, Figozap, Glapira, Zedilarf
- Sweden
- Daforbis, Dapagliflozin Adalvo, Dapagliflozin Alembic, Dapagliflozin Devatis, Dapagliflozin Krka, Dapagliflozin Orion, Dapagliflozin Reddy, Dapagliflozin Sandoz, Dapagliflozin Stada, Dapagliflozin Vivanta, Figozap
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Related calculators
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Edistride – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/edistride-epar-product-information_en.pdf
- European Medicines Agency. Forxiga – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/forxiga-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC A10BK.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.